Facility Design and Engineering

Jun 10, 2016
By BioPharm International Editors
Alvotech prepares for commercial biosimilar production in new facility with single-use bioreactors in Reykjavik, Iceland.
May 02, 2016
By BioPharm International Editors
EMD Serono, the North American biopharmaceutical business of Germany’s Merck KGaA, will expand its R&D facility in Massachusetts, US.
May 02, 2016
By BioPharm International Editors
MilliporeSigma, the North American life-sciences business of Germany’s Merck KGaA, added a 2000-L single-use bioreactor to its facility in Massachusetts.
Apr 18, 2016
By BioPharm International Editors
Shire announces plans to build a flexible biopharmaceutical manufacturing facility in County Meath, Ireland.
Mar 29, 2016
By BioPharm International Editors
Novo Nordisk broke ground on a facility in Clayton, NC, to manufacture APIs for GLP-1 and insulin medicines.
Mar 29, 2016
By BioPharm International Editors
A team of Bristol-Myers Squibb scientists will work in a new laboratory at the National Institute of Bioprocessing Research and Training facility in Dublin, Ireland.
Mar 02, 2016
BioPharm International
Asking the right questions is crucial to establishing a biopharmaceutical facility design.
Mar 02, 2016
By BioPharm International Editors
TxCell’s new facilities are based in Sophia Antipolis, France, on the premises of GenBiotech.
Feb 02, 2016
By BioPharm International Editors
The International Society for Pharmaceutical Engineering (ISPE) Facility of the Year Awards (FOYA) program announced its 2016 Category Award winners for operational excellence, sustainability, process innovation, project execution, equipment innovation, and facility integration.
Jan 28, 2016
By BioPharm International Editors
Novasep is building a new synthesis laboratory and adding capacity for kilogram-scale batches of synthetic molecules that are needed for biological testing and preclinical trials, at its Pennsylvania, US facility.
native1_300x100
lorem ipsum